🔎 Trials Near Me

Home › Triple-Negative Breast Cancer › Missouri › Kansas City

Triple-Negative Breast Cancer clinical trials in Kansas City, MO

6 studies for Triple-Negative Breast Cancer are looking for participants at sites in and around Kansas City (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

RecruitingPhase 3
  • Saint Luke's Cancer Institute ( Site 0059), Kansas City
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06966700

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

RecruitingPhase 1
  • University of Kansas, Westwood · 5 mi away
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07020117

Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

RecruitingObservational studyHealthy volunteers welcome
  • Universtiy Health, Kansas City
  • KCCC South, Kansas City
  • Research Medical Center, Kansas City
  • and 2 more
All ages · All sexes · Updated Aug 18, 2026 · NCT02302742

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

RecruitingPhase 1/2
  • University of Kansas Medical Center (KUMC), Westwood · 5 mi away
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT05579366

A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer

RecruitingPhase 1/2
  • The University of Kansas Hospital, Westwood · 5 mi away
Ages 18 and older · All sexes · Updated Jan 30, 2026 · NCT06926920

Triple-Negative Breast Cancer trials in other cities

Other studies in Kansas City

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.